Jeremy Findlay

430 total citations
14 papers, 322 citations indexed

About

Jeremy Findlay is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Jeremy Findlay has authored 14 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 4 papers in Organic Chemistry. Recurrent topics in Jeremy Findlay's work include Neuroscience and Neuropharmacology Research (7 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Ion channel regulation and function (3 papers). Jeremy Findlay is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Ion channel regulation and function (3 papers). Jeremy Findlay collaborates with scholars based in United Kingdom, United States and Spain. Jeremy Findlay's co-authors include Ian A. Pullar, P. T. Gallagher, Louise Wallace, David T. Wong, David W. Robertson, S.N. Mitchell, Joseph H. Krushinski, David C. Thompson, F.P. Bymaster and John R. Boot and has published in prestigious journals such as Scientific Reports, Journal of Neurochemistry and Neuropharmacology.

In The Last Decade

Jeremy Findlay

14 papers receiving 308 citations

Peers

Countries citing papers authored by Jeremy Findlay

Since Specialization

Citations

This map shows the geographic impact of Jeremy Findlay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy Findlay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy Findlay more than expected).

Fields of papers citing papers by Jeremy Findlay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy Findlay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy Findlay. The network helps show where Jeremy Findlay may publish in the future.

Co-authorship network of co-authors of Jeremy Findlay

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy Findlay. A scholar is included among the top collaborators of Jeremy Findlay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy Findlay. Jeremy Findlay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	A high-throughput model for investigating neuronal function and synaptic transmission in cultured neuronal networks 2017 ·Scientific Reports ·(unknown), (unknown), Antoine Fouillet, Jeremy Findlay, Filipa M. Ferreira, (unknown), Michael J. O’Neill, (unknown), Daniel Ursu	14
2	An Integrated Approach for Screening and Identification of Positive Allosteric Modulators of N-Methyl-D-Aspartate Receptors 2016 ·SLAS DISCOVERY ·Enrique Jambrina, Rok Cerne, Emery Smith, Louis Scampavia, María José Cuadrado, Jeremy Findlay, Michael J. Krambis, Mark Wakulchik, Peter Chase, (unknown), Kevin D. Burris, P. T. Gallagher, Timothy Spicer, Daniel Ursu	12
3	Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR 2012 ·Neuropharmacology ·Helen Sanger, Lydia Hanna, (unknown), Olivera Grubisha, Daniel Ursu, Beverly A. Heinz, Jeremy Findlay, (unknown), Emanuele Sher, David Lodge, James A. Monn, Lisa M. Broad	22
4	Naphthyl piperazines with dual activity as 5-HT1D antagonists and 5-HT reuptake inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Ana B. Bueno, Jeremy Gilmore, John R. Boot, (unknown), Jane Cooper, Jeremy Findlay, (unknown), (unknown), Carlos Closa, Stephen N. Mitchell, (unknown), Rosemarie Tomlinson, Louise Wallace, (unknown)	6
5	The Retinol-binding Protein System: A Potential Paradigm for Steroid-binding Globulins? 2006 ·Hormone and Metabolic Research ·C Redondo, Brian Burke, Jeremy Findlay	11
6	1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·Christopher D. Beadle, John R. Boot, Nicholas P. Camp, (unknown), Jeremy Findlay, (unknown), John J. Masters, (unknown), Magnus W. Walter	32
7	Novel selective and potent 5-HT reuptake inhibitors with 5-HT1D antagonist activity: chemistry and pharmacological evaluation of a series of thienopyran derivatives 2004 ·Bioorganic & Medicinal Chemistry ·Alicia Torrado, Carlos José Einicker Lamas, Javier Agejas, Alma Jiménez, Nuria Cirauqui, Jeremy Gilmore, John R. Boot, Jeremy Findlay, (unknown), Louise Wallace, (unknown), Rosemarie Tomlinson	12
8	Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin and norepinephrine reuptake 2004 ·Bioorganic & Medicinal Chemistry Letters ·J.R. Boot, (unknown), (unknown), (unknown), (unknown), Jeremy Findlay, P. T. Gallagher, (unknown), S. Mahadevan, (unknown), (unknown), (unknown), (unknown), Louise Wallace, (unknown)	16
9	Discovery and structure–activity relationships of novel selective norepinephrine and dual serotonin/norepinephrine reuptake inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·John R. Boot, (unknown), Barry P. Clark, Jeremy Findlay, P. T. Gallagher, (unknown), (unknown), Christian Montalbetti, (unknown), Hélène Rudyk, Magnus W. Walter, (unknown), (unknown)	27
10	SAR development of a selective 5-HT1D antagonist/serotonin reuptake inhibitor lead using rapid parallel synthesis 2004 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), John R. Boot, (unknown), (unknown), Jane Cooper, Jeremy Findlay, Jeremy Gilmore, Stephen N. Mitchell, Nick Moore, Ian A. Pullar, (unknown), (unknown), (unknown), (unknown)	9
11	Duloxetine (Cymbalta), a Dual Inhibitor of Serotonin and Norepinephrine Reuptake. 2004 ·ChemInform ·Frank P. Bymaster, (unknown), Jeremy Findlay, P. T. Gallagher, Joseph H. Krushinski, S.N. Mitchell, David W. Robertson, David C. Thompson, Louise Wallace, David T. Wong	5
12	Duloxetine (Cymbalta™), a dual inhibitor of serotonin and norepinephrine reuptake 2003 ·Bioorganic & Medicinal Chemistry Letters ·F.P. Bymaster, (unknown), Jeremy Findlay, P. T. Gallagher, Joseph H. Krushinski, S.N. Mitchell, David W. Robertson, David C. Thompson, Louise Wallace, David T. Wong	93
13	ω-Agatoxin IVA identifies a single calcium channel subtype which contributes to the potassium-induced release of acetylcholine, 5-hydroxytryptamine, dopamine, γ-aminobutyric acid and glutamate from rat brain slices 1996 ·Neuropharmacology ·(unknown), (unknown), Jeremy Findlay, (unknown), Ian A. Pullar	39
14	Effect of Voltage‐Sensitive Calcium Channel Antagonists on the Release of 5‐Hydroxytryptamine from Rat Hippocampus In Vivo 1992 ·Journal of Neurochemistry ·Ian A. Pullar, Jeremy Findlay	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact